Financial Advocates Investment Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Hold |
23,000
| – | – | 0.02% | 533 |
|
|
2025
Q1 | $283K | Hold |
23,000
| – | – | 0.02% | 574 |
|
|
2024
Q4 | $257K | Buy |
23,000
+5,000
| +28% | +$56K | 0.01% | 638 |
|
|
2024
Q3 | $125K | Buy |
18,000
+3,000
| +20% | +$20.9K | 0.01% | 728 |
|
|
2024
Q2 | $113K | Buy |
15,000
+5,000
| +50% | +$37.8K | 0.01% | 689 |
|
|
2024
Q1 | $132K | Hold |
10,000
| – | – | 0.01% | 724 |
|
|
2023
Q4 | $103K | Hold |
10,000
| – | – | 0.01% | 700 |
|
|
2023
Q3 | $97.3K | Hold |
10,000
| – | – | 0.01% | 670 |
|
|
2023
Q2 | $44.9K | Hold |
10,000
| – | – | ﹤0.01% | 681 |
|
|
2023
Q1 | $46.4K | Hold |
10,000
| – | – | ﹤0.01% | 719 |
|
|
2022
Q4 | $14.9K | Hold |
10,000
| – | – | ﹤0.01% | 740 |
|
|
2022
Q3 | $38K | Buy |
+10,000
| New | +$38K | ﹤0.01% | 730 |
|